Abstract
Valve‐in‐valve (ViV) procedures for failing bioprostheses carry a certain risk for device malfunction. We herein report a case of a failing Evolut R in a deteriorated Mitroflow, treated with a Sapien 3.An 81 year old female patient received surgical aortic valve replacement and was treated by ViV due to deterioration. Three years later, echocardiography revealed a pressure gradient of peak/mean 105/63 mmHg. Subsequently, a second ViV procedure with initial intentional rupture of the bioprosthetic stent was performed. Immediate stent recoil of the Evolut R prompted implantation of a Sapien 3. In 30‐day follow‐up, mean pressure gradient of 30 mmHg and nearly complete symptom relief was documented.Fracture of a surgical bioprosthetic stent is feasible in a ViV configuration. Supra‐annular placement of a balloon‐expandable THV as ViV‐in‐valve is feasible with suboptimal hemodynamic results in this case. Risk of re‐do surgery should be weighted against anticipated hemodynamic and clinical results.

This publication has 8 references indexed in Scilit: